Medical Imaging Market Overview:
IMARC Group, a leading market research company, has recently releases report titled “Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” the global medical imaging market size reached US$ 39.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 57.0 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
What are Medical Imaging?
Medical imaging refers to the technique of creating visual depictions of the human body for diagnosing an ailment and its subsequent medical treatment. Computed tomography (CT) scanners, magnetic resonance imaging (MRI), nuclear imaging, mammography, and ultrasound are common medical imaging systems. It is a non-invasive technique that helps medical professionals to assess patients’ bones, organs, tissue, and blood vessels. Medical imaging tests are safe, quick, and easy to perform and aid in early and accurate diagnosis, understanding complications, and eliminating the need for exploratory surgery. As a result, medical imaging is widely used in cardiovascular and thoracic, orthopedics and musculoskeletal, obstetrics and gynecology, and neurology departments.
Request for a free sample copy of this report: https://www.imarcgroup.com/medical-imaging-market/requestsample
What are the growth prospects and trends in the industry?
The significant growth in the healthcare industry across the globe is creating a positive outlook for the market. In line with this, the growing occurrence of lifestyle diseases owing to sedentary lifestyles and age-related ailments in the steadily rising geriatric population is also favoring the market growth. Medical imaging is widely used by healthcare specialties to diagnose diseases and injuries, such as cancer, heart blockage, fractures, and tumors. Apart from this, the introduction of three-dimensional (3D) imaging technology to develop enhanced resolutions and more intricate details for better patient care is providing an impetus to the market growth. Moreover, the integration of artificial intelligence (AI) to enhance tissue-based detection and provide accuracy and sensitivity in the identification of imaging abnormalities is acting as another growth-inducing factor.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- CT Scanners
- X-Ray Imaging Systems
- MRI Systems
- Ultrasound Imaging Systems
- Nuclear Imaging Systems
- Mammography Systems
Breakup by Application:
- Obstetrics and Gynecology Health
- Orthopedics and Musculoskeletal
- Neuro and Spine
- Cardiovascular and Thoracic
- General Imaging
- Breast Health
- Others
Breakup by End User:
- Hospitals
- Diagnostic Centers
- Academic Institutes and Research Organizations
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Canon Medical Systems Corporation (Canon Inc.)
- Carestream Health
- Cubresa Inc.
- Esaote SpA
- FUJIFILM VisualSonics Inc.
- GE HealthCare (General Electric Company)
- Hologic Inc.
- Koning Corporation
- Koninklijke Philips N.V.
- Materialise NV
- Mindray Medical International Limited
- Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.)
- Siemens Healthineers AG (Siemens AG).
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
